# Hypertension (Hypertensive Urgency/Uncontrolled HTN) - Acute Care Pathway

## Objective
Enable physiologic monitoring and geographically-distributed care coordination to ensure effective care for patients with uncontrolled hypertension refractory to outpatient management requiring IV medication, oral titration, or dosage optimization.

## Duration
**2-4 days** (typical 2-3 days)

---

## Eligibility Criteria

### Inclusion
- **Uncontrolled hypertension** refractory to outpatient management requiring:
  - IV medication, OR
  - Oral medication titration/optimization, OR
  - Close monitoring during dosage adjustments

### Exclusion Criteria
- **Hypertensive emergency** (end-organ damage) - requires hospital ICU
- **Continuous IV infusion** requirement
- **Labile blood pressure** with recurrent hypotension

---

## Primary Outcome Measures

| Outcome | Timeframe | Target |
|---------|-----------|--------|
| **30-Day ED Presentation** | 30 days | Minimize HTN-related ED visits |
| **30-Day Readmission** | 30 days | <10% |
| **30-Day Mortality** | 30 days | <2% |
| **Patient Satisfaction** | End of program | >85% satisfaction |

---

## Devices & Monitoring Equipment

See **[Devices Reference](../../shared/devices.md)** for complete specifications.

### Required Devices
- **Connected BP Cuff** (Welch Allyn 1700 OR Omron BP7000)
  - **Critical**: Multiple daily BP readings are cornerstone of HTN monitoring

### Optional Devices (based on severity and clinician preference)
- **Continuous Telemetry** (VitalConnect VitalPatch)*
  - For patients with cardiac complications or arrhythmia history
- **Connected Pulse Oximeter** (Nonin 3230)*
- **Oral Thermometer*

---

## Daily Monitoring Protocol

### Clinical Team Reviews (Daily)
1. **Physiologic Data Review**
   - **BP trends**: Multiple daily readings (morning, afternoon, evening)
   - **Heart rate**: Monitor for tachycardia (hypertensive urgency) or bradycardia (beta-blocker)
   - **Orthostatic vitals**: If patient reports dizziness

2. **Subjective Patient Data Review**
   - **Daily HTN Symptom Checker**: See **[HTN Questionnaire](../../shared/questionnaires/htn-questionnaire.md)**
     - Severe headache (hypertensive urgency)
     - Chest pain (ACS, hypertensive emergency)
     - Shortness of breath (pulmonary edema)
     - Dizziness/lightheadedness (hypotension from over-treatment)
     - Visual abnormalities (hypertensive retinopathy)
     - Confusion (hypertensive encephalopathy)

3. **Patient Task Compliance**
   - BP measurements twice daily minimum
   - Medication adherence (new/adjusted doses)
   - Dietary salt intake tracking

---

## Alert Thresholds & Escalations

See **[Universal Alert Thresholds](../../shared/alert-thresholds.md)** for complete table.

### HTN-Specific Critical Alerts

| BP Reading | With Symptoms | Without Symptoms | Action |
|------------|---------------|------------------|--------|
| **SBP ≥180 or DBP ≥110** | **Hypertensive urgency** | Asymptomatic severe HTN | **Urgent (2-4 hrs)**: Oral antihypertensive, close monitoring |
| **SBP ≥180/120 + End-organ symptoms** | **HYPERTENSIVE EMERGENCY** | N/A | **IMMEDIATE (911)**: Hospital transfer |
| **SBP <90** | Symptomatic hypotension | Asymptomatic | Hold antihypertensives, assess volume, clinical evaluation |
| **SBP 90-100 + dizziness** | Borderline low | — | Hold next dose, reassess |

### Symptom-Based Emergency Criteria (Call 911)
- **Chest pain** + SBP ≥180: Possible ACS or aortic dissection
- **Severe dyspnea** + SBP ≥180: Flash pulmonary edema
- **Confusion/altered mental status** + SBP ≥180: Hypertensive encephalopathy
- **Vision loss** + SBP ≥180: Hypertensive retinopathy/PRES
- **Severe headache** + confusion + SBP ≥180: Hypertensive encephalopathy

---

## Care Coordination

### Telemedicine/Virtual Visits
- **Daily check-ins** during medication titration (first 48-72 hours)
- **Every 2 days** thereafter if BP stabilizing
- **Ad-hoc visits** for medication adjustments, side effect management

### Interdisciplinary Task Management
- **Phlebotomy**: Home blood draws for BMP (renal function, electrolytes)
- **Antihypertensive Administration**: Ensure patient has prescriptions, can self-administer

---

## Treatment Protocol

### Medication Management

#### Oral Antihypertensives for Hypertensive Urgency
**Goal**: Lower BP by 20-25% over 24-48 hours (NOT precipitous drop)

**First-Line Options**:
- **Clonidine** 0.1-0.2mg PO, repeat q1hr PRN (max 0.6mg)
- **Captopril** 25mg PO, repeat in 1-2 hrs if needed
- **Labetalol** 200-400mg PO, repeat q2-3hrs PRN

**Avoid**: Sublingual nifedipine (unpredictable, precipitous drops)

#### Long-Term BP Control Optimization
**Guideline-Directed Therapy (GDMT)**:
- **ACE inhibitors / ARBs**: First-line (lisinopril, losartan)
- **Calcium channel blockers**: Add-on (amlodipine)
- **Thiazide diuretics**: Add-on (hydrochlorothiazide, chlorthalidone)
- **Beta-blockers**: If compelling indication (CHF, CAD, post-MI)

**Combination Therapy** (most patients require 2-3 agents):
- ACE-I/ARB + Thiazide
- ACE-I/ARB + CCB
- ACE-I/ARB + CCB + Thiazide (triple therapy)

#### BP Targets
- **General population**: <140/90 mmHg
- **Diabetes or CKD**: <130/80 mmHg
- **Elderly (>65)**: <130 systolic, but avoid <120 (increased fall risk)

### Monitoring During Titration
- **BP measurements**: Twice daily minimum (morning and evening)
- **BMP**: Every 2-3 days (monitor for hyperkalemia with ACE-I/ARB, renal function)
- **Orthostatic vitals**: If dizziness reported

---

## Complications to Monitor

### Hypertensive Emergency (Requires Hospital Transfer)
**End-Organ Damage Signs**:
- **CNS**: Hypertensive encephalopathy, stroke, PRES
- **Cardiac**: Acute MI, acute CHF, aortic dissection
- **Renal**: Acute kidney injury
- **Retinal**: Papilledema, hemorrhages

**Action**: **IMMEDIATE 911 call**, do NOT attempt to lower BP at home

### Hypotension (Over-Treatment)
**Signs**:
- Dizziness, lightheadedness
- SBP <90 mmHg
- Orthostatic drop >20 systolic

**Management**:
- Hold antihypertensives
- Increase fluid intake
- Reduce medication doses
- Re-evaluate medication regimen

### Medication Side Effects
- **ACE-I**: Dry cough (10-15%), hyperkalemia, angioedema (rare)
- **ARB**: Hyperkalemia, dizziness
- **CCB**: Peripheral edema (ankles), constipation, headache
- **Thiazides**: Hypokalemia, hyperglycemia, hyperuricemia
- **Beta-blockers**: Fatigue, bradycardia, erectile dysfunction

---

## Comorbidity Management

See **[Comorbidity Matrix](../../shared/comorbidity-matrix.md)** for detailed guidance.

### Common HTN Comorbidities
- **HTN + CHF**: ACE-I/ARB + beta-blocker essential; avoid hypotension from over-diuresis
- **HTN + Diabetes**: Target BP <130/80; ACE-I/ARB first-line for renal protection
- **HTN + Hyperlipidemia**: Statin therapy; metabolic syndrome screening
- **HTN + CKD**: ACE-I/ARB for renal protection; monitor potassium and creatinine

---

## Transition to Post-Acute Care

### Discharge Readiness Criteria
- ✅ BP controlled below target (<140/90 or individualized target)
- ✅ BP stable for 24-48 hours on new regimen
- ✅ No symptomatic hypotension
- ✅ Patient tolerating medications (no severe side effects)
- ✅ BMP stable (K normal, Cr not elevated)
- ✅ Patient educated on medication regimen and home BP monitoring

### Handoff to Post-Acute
See **[Transition to Post-Acute](./transition-to-postacute.md)** for full protocol.

**Key Handoff Information**:
- Final medication regimen (drug, dose, frequency)
- Target BP range
- Medication side effects to monitor
- Dietary recommendations (low sodium)
- Follow-up with PCP/cardiologist scheduled

---

## References
- Source: Carepath Hypertension Acute Care Pathway SOP
- ACC/AHA Hypertension Guidelines 2017
- Peixoto AJ. Acute Severe Hypertension. N Engl J Med 2019.

**Related Skills**: After stabilization, patient transitions to `carepath-postacute` skill for 30-day BP control monitoring and medication adherence.
